Select Language

BCHE

BCHE Overview

English Name	Butyrylcholinesterase	Approved Drugs	2
Drugs in Clinical Trials	1	Target Synonym	BCHED，CHE2，E1，Butyrylcholinesterase，BuChE，EC:3.1.1.8，EC 3.1.1，BCHE，Acylcholine acylhydrolase，Pseudocholinesterase，Cholinesterase，CHE1，Cholinesterase (Serum) 2，Butyrylcholine Esterase，Choline Esterase II，Cholinesterase 1，EC 3.1.1.8
Highest Development Stage	Approved

English Name	Butyrylcholinesterase
Target Synonym	BCHED，CHE2，E1，Butyrylcholinesterase，BuChE，EC:3.1.1.8，EC 3.1.1，BCHE，Acylcholine acylhydrolase，Pseudocholinesterase，Cholinesterase，CHE1，Cholinesterase (Serum) 2，Butyrylcholine Esterase，Choline Esterase II，Cholinesterase 1，EC 3.1.1.8
Approved Drugs	2
Drugs in Clinical Trials	1
Highest Development Stage	Approved

BCHE Product List

Product Category
Protein (1)
Product Status
Launched (1)
Species
Human (1)
Tag
His Tag (1)
Conjugate
Unconjugated (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature
BHE-H52H3	Human	HEK293	Human BCHE / Butyrylcholinesterase Protein, His Tag (active enzyme)

Total: 1

BCHE Background

belongs to the small leucine-rich proteoglycan (SLRP) family and SLRP class II subfamily.

BCHE Synonyms

Acylcholine acylhydrolase,BCHE,Butyrylcholine esterase,Butyrylcholinesterase,CHE1,CHE1cholinesterase,Choline esterase II,cholinesterase 1,E1,EC 3.1.1.8,Pseudocholinesterase

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
Bisnorcymserine	ANVS-301	Phase 1 Clinical	Horizon Therapeutics PLC, National Institute On Aging (NIA)	Alzheimer Disease	Details

Marketed Drug Information

English Name	Research Code	Highest Development Stage	Company	Earliest Brand Name	Earliest Approval Country	Earliest Indication	Earliest Approval Company	Earliest Approval Date	Indication	Clinical Trial
Rivastigmine Tartrate	SDZ-212-713; SDZ 212713; SDZ-ENA-713; ONO-2540; ENA-713; ENA-713D	Approved	Novartis Pharma Ag	Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能	EU	Alzheimer Disease; Parkinson Disease; Dementia	Novartis Europharm Ltd	1998-05-11	Alzheimer Disease; Anticholinergic Syndrome; Brain Injuries, Traumatic; Cocaine-Related Disorders; Cognition Disorders; Delirium; Dementia; Dementia, Vascular; Down Syndrome; Neurobehavioral Manifestations; Parkinson Disease; Substance-Related Disorders	Details
Rivastigmine Twice Weekly Transdermal Patch (Luye Pharma)	LY-03013; LY-30410; RID-TDS	Approved	Acino International AG	Rivirec, 金斯明, Kingsmin, Rivalif®	Mainland China	Alzheimer Disease	Luye Pharma Group Ltd		Alzheimer Disease; Parkinson Disease	Details